ArticleLancet regional health. Americas2023

Marketing authorisation and pricing of FDA-approved cancer drugs in Brazil: a retrospective analysis.

Adriana M Ivama-Brummell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.